Discovery Laboratories Inc. (Nasdaq: DSCO) received an FDA nod to proceed with studies to treat infant respiratory problems sending the stock price up 33 cents to $1.44.
Discovery Labs Receives FDA Approval
September 30, 2009 at 13:47 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.